Clinical trial
Treatment of PD-1 Inhibitor in AIDS-associated PML
NCT04091932
Study timeline
Study start (actual)2019-08-20Date precision: day
Registry last updated2019-09-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
AIDSunresolved
Interventions
PembrolizumabDRUG · verified · RxNorm: pembrolizumab
Sponsors & collaborators
First Affiliated Hospital of Zhejiang Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04091932 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.